Skip to main content
SAREUM HOLDINGS PLC logo

SAREUM HOLDINGS PLC — Investor Relations & Filings

Ticker · SAR ISIN · GB00BMC3RJ87 LEI · 213800PKERN2DY8FFM72 IL Manufacturing
Open in API
Filings indexed 348 across all filing types
Latest filing 2024-05-07 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL SAR

About SAREUM HOLDINGS PLC

https://www.sareum.com/

Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.

Recent filings

Filing Released Lang Actions
Exercise of Warrants
Share Issue/Capital Change Classification · 99% confidence The document is identified by the header 'RNS Number' and contains information about the exercise of warrants, resulting in the issuance of new ordinary shares and an update to the total voting rights. This type of announcement, which details a specific corporate action (share issuance/capital change) and is distributed via the RNS system (London Stock Exchange's news service), fits best under the category of general regulatory announcements or specific capital changes. Since it explicitly details the issuance of new shares following warrant exercise, it strongly relates to 'Share Issue/Capital Change' (SHA). However, the presence of the RNS header and the nature of the announcement (a formal update to the market via the LSE's service) also suggests a general regulatory filing. Given the specific action is a share issuance/capital change, SHA is highly relevant. If SHA were not available, RNS would be the fallback. Since the document details the issuance of new shares and the resulting total voting rights, SHA is the most precise fit. The document length is short (4388 chars), but it is a primary announcement, not just an announcement *of* another report, so RPA/RNS is less appropriate than the specific action code SHA.
2024-05-07 English
Final Issue of RiverFort Subscription Shares
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Final Issue of RiverFort Subscription Shares,' which involves the issuance of new ordinary shares and the resulting change in total voting rights. This is a specific corporate action announcement made via the Regulatory News Service (RNS). Since it is a direct regulatory announcement that doesn't fit the specific categories like DIV, SHA, or CAP (though it relates to capital), the most appropriate general regulatory filing category is RNS, especially given the explicit RNS branding and structure.
2024-04-23 English
Issue of RiverFort Subscription Shares
Regulatory Filings Classification · 98% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the FCA. The content details the 'Issue of RiverFort Subscription Shares' and the subsequent admission to trading, which directly impacts the total number of shares and voting rights. This type of corporate action announcement, which is not a full financial report (like 10-K or IR) but a specific regulatory update concerning share capital changes, fits best under the 'Share Issue/Capital Change' category (SHA). Although it is distributed via RNS, SHA is more specific than the general 'RNS' fallback.
2024-04-19 English
Issue of RiverFort Subscription Shares
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and contains an announcement dated 15 April 2024 regarding the 'Issue of RiverFort Subscription Shares' and subsequent 'Admission' to trading on AIM. It details the issuance of 3,000,000 new Ordinary Shares and updates the total voting rights. This type of immediate, material corporate action announcement, distributed via the RNS service, fits the description of a general regulatory announcement that doesn't fit a more specific financial report category (like 10-K, ER, or IR). Since it is a formal announcement distributed through the official news service (RNS), and it is not a specific report like an Earnings Release (ER) or Interim Report (IR), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such disclosures.
2024-04-15 English
Issue of RiverFort Subscription Shares
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains an announcement dated 09 April 2024 regarding the 'Issue of RiverFort Subscription Shares'. This involves the issuance of new ordinary shares and subsequent admission to trading on AIM, which directly relates to capital structure changes and share issuance. This fits the definition of 'Share Issue/Capital Change' (SHA). Although it is distributed via RNS, the core subject matter is a specific capital action, making SHA a more precise classification than the general 'RNS' fallback. The document length (4681 chars) is substantial enough to be the primary announcement, not just a notification of publication.
2024-04-09 English
Completion of Equity Fundraise
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number: 3788J) on April 4, 2024. The primary subject is the 'Completion of Equity Fundraise' involving the issue of new Ordinary Shares through a Placing, Subscription, and WRAP Retail Offer, raising gross proceeds of £2.29m. It details the number of shares issued, the price, and confirms the subsequent 'Admission' of these new shares to trading on AIM, along with the resulting 'Total Voting Rights'. Crucially, the document concludes with PDMR (Persons Discharging Managerial Responsibilities) notifications detailing insider transactions related to the fundraise. This content—announcing a significant capital raising event, share issuance, and subsequent director dealings—fits squarely under the 'Capital/Financing Update' category (CAP). While it is an RNS announcement, the specific, detailed nature of the capital event makes CAP a more precise classification than the general RNS fallback.
2024-04-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.